Back
Praxis Precision Medicines 10K Form
Sell
39
PRAX
Praxis Precision Medicines
Last Price:
54.87
Seasonality Move:
-34.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PRAX News And Ratings
See the #1 stock for the next 7 days that we like better than PRAX
PRAX Financial Statistics
Sales & Book Value
Annual Sales: | $2.45M |
---|---|
Cash Flow: | $-23.86M |
Price / Cash Flow: | 0 |
Annual Sales: | $7.92 |
Price / Book: | 10.05 |
Profitability
EPS (TTM): | -22.59000 |
---|---|
Net Income (TTM): | $-123.28M |
Gross Margin: | -- |
Return on Equity: | -153.09% |
Return on Assets: | -115.6% |
Praxis Precision Medicines Earnings Forecast
Key Praxis Precision Medicines Financial Ratios
- The Research & Development expenses have been 3,545.81% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 2 years.
Praxis Precision Medicines Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | PRAX |
CUSIP: | 74006W |
Website: | praxismedicines.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.39 |
Quick Ratio: | 5.16 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
PRAX Technical Analysis vs Fundamental Analysis
Sell
39
Praxis Precision Medicines (PRAX)
is a Sell
Is Praxis Precision Medicines a Buy or a Sell?
-
Praxis Precision Medicines stock is rated a Sell
The current Praxis Precision Medicines [PRAX] share price is $52.88. The Score for PRAX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.